Now showing items 1-1 of 1

    • High Potency Drug Screening in Neuroendocrine Prostate Cancer 

      Khan, Raymond 1983- (2018-07-27)
      Neuroendocrine Prostate Cancer (NEPC) is an aggressive subtype of prostate cancer, affecting approximately 2% of all prostate cancer patients. While NEPC is a rare disease, it has no known treatment and often leads to death ...